• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.验证肾衰竭风险方程在预测新加坡多民族慢性肾脏病队列进展为肾衰竭风险中的作用。
Singapore Med J. 2022 Jun;63(6):313-318. doi: 10.11622/smedj.2020170. Epub 2020 Dec 2.
2
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.验证东南亚终末期肾脏病风险方程对肾衰竭的预测效果。
BMC Nephrol. 2019 Dec 4;20(1):451. doi: 10.1186/s12882-019-1643-0.
3
The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.用于预测英国初级保健中终末期肾病的肾衰竭风险方程:外部验证和临床影响预测队列研究。
PLoS Med. 2019 Nov 6;16(11):e1002955. doi: 10.1371/journal.pmed.1002955. eCollection 2019 Nov.
4
Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation.在一个种族多样化的 2 型糖尿病患者队列中调查终末期肾病风险预测:使用肾功能衰竭风险方程。
BMJ Open Diabetes Res Care. 2024 Sep 13;12(4):e004282. doi: 10.1136/bmjdrc-2024-004282.
5
Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race : A Prospective Cohort Study.基于是否考虑种族因素的估算肾小球滤过率预测终末期肾病:一项前瞻性队列研究。
Ann Intern Med. 2022 Mar;175(3):305-313. doi: 10.7326/M21-2928. Epub 2022 Jan 11.
6
Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.应用肾衰竭风险方程评估慢性肾脏病儿童进展至终末期肾病的风险。
JAMA Pediatr. 2018 Feb 1;172(2):174-180. doi: 10.1001/jamapediatrics.2017.4083.
7
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.根据病因对晚期慢性肾脏病的肾衰竭风险方程进行验证研究,评估其区分度、校准度和临床实用性。
BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1.
8
Validation of the kidney failure risk equation in European CKD patients.验证欧洲慢性肾脏病患者的肾衰竭风险方程。
Nephrol Dial Transplant. 2013 Jul;28(7):1773-9. doi: 10.1093/ndt/gft063. Epub 2013 May 3.
9
Effect of Glomerular Filtration Rate by Different Equations on Prediction Models for End-Stage Renal Disease in Diabetes.不同方程计算的肾小球滤过率对糖尿病终末期肾病预测模型的影响
Front Endocrinol (Lausanne). 2022 Jun 3;13:873318. doi: 10.3389/fendo.2022.873318. eCollection 2022.
10
Validation of the kidney failure risk equation in a Portuguese cohort.验证在葡萄牙队列中衰竭风险方程。
Nefrologia (Engl Ed). 2023 Jul-Aug;43(4):467-473. doi: 10.1016/j.nefroe.2022.03.007. Epub 2022 Dec 16.

引用本文的文献

1
Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.重新校准地中海欧洲人群的肾衰竭风险方程:减少年龄和性别不平等。
Front Med (Lausanne). 2025 Jan 29;11:1497780. doi: 10.3389/fmed.2024.1497780. eCollection 2024.
2
Predictive Value of Kidney Failure Risk Equation and Neutrophil Gelatinase-Associated Lipocalin for Chronic Kidney Disease Progression in Chinese Population - A Retrospective Study.肾衰竭风险方程和中性粒细胞明胶酶相关脂质运载蛋白对中国人群慢性肾脏病进展的预测价值——一项回顾性研究
Int J Gen Med. 2024 Dec 30;17:6557-6565. doi: 10.2147/IJGM.S497268. eCollection 2024.
3
Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review.多病症和虚弱在肾衰竭预后预测模型的开发和验证中的表现:系统评价。
BMC Med. 2024 Oct 11;22(1):452. doi: 10.1186/s12916-024-03649-9.
4
Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus.2 型糖尿病患者慢性肾脏病的风险预测和管理。
Diabetes Metab J. 2024 Mar;48(2):196-207. doi: 10.4093/dmj.2023.0244. Epub 2024 Jan 26.
5
Multicentre external validation of the prognostic model kidney failure risk equation in patients with CKD stages 3 and 4 in Peru: a retrospective cohort study.秘鲁慢性肾脏病 3 期和 4 期患者中预测模型肾衰竭风险方程的多中心外部验证:回顾性队列研究。
BMJ Open. 2024 Jan 6;14(1):e076217. doi: 10.1136/bmjopen-2023-076217.
6
ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.中国多中心慢性肾脏病队列中的终末期肾病风险预测模型:一项推导、验证及比较研究
J Clin Med. 2023 Feb 14;12(4):1504. doi: 10.3390/jcm12041504.

本文引用的文献

1
Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health.预测发达国家慢性肾脏病的负担及其对公共卫生的影响。
Int J Nephrol. 2018 Jul 4;2018:5196285. doi: 10.1155/2018/5196285. eCollection 2018.
2
Risk-Based Triage for Nephrology Referrals Using the Kidney Failure Risk Equation.使用肾衰竭风险方程进行肾脏科转诊的基于风险的分诊
Can J Kidney Health Dis. 2017 Aug 9;4:2054358117722782. doi: 10.1177/2054358117722782. eCollection 2017.
3
Con: Most clinical risk scores are useless.反对观点:大多数临床风险评分毫无用处。
Nephrol Dial Transplant. 2017 May 1;32(5):752-755. doi: 10.1093/ndt/gfx073.
4
A Dynamic Predictive Model for Progression of CKD.慢性肾脏病进展的动态预测模型。
Am J Kidney Dis. 2017 Apr;69(4):514-520. doi: 10.1053/j.ajkd.2016.07.030. Epub 2016 Sep 29.
5
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.
6
Risk Prediction in CKD: The Rational Alignment of Health Care Resources in CKD 4/5 Care.慢性肾脏病的风险预测:慢性肾脏病4/5期护理中医疗资源的合理配置
Adv Chronic Kidney Dis. 2016 Jul;23(4):227-30. doi: 10.1053/j.ackd.2016.04.002.
7
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.预测肾衰竭风险方程准确性的多国评估:一项荟萃分析。
JAMA. 2016 Jan 12;315(2):164-74. doi: 10.1001/jama.2015.18202.
8
Long-term diabetes outcomes in multi-ethnic Asians living in Singapore.居住在新加坡的多民族亚洲人的长期糖尿病转归
Diabetes Res Clin Pract. 2016 Jan;111:83-92. doi: 10.1016/j.diabres.2015.09.019. Epub 2015 Oct 27.
9
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年:全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.
10
Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.慢性肾脏病进展至终末期肾病:关于潜在肾脏疾病作用的单中心经验
Ther Apher Dial. 2013 Aug;17(4):363-7. doi: 10.1111/1744-9987.12079.

验证肾衰竭风险方程在预测新加坡多民族慢性肾脏病队列进展为肾衰竭风险中的作用。

Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.

机构信息

Department of Renal Medicine, Singapore General Hospital, Singapore.

MOH Holdings Pte Ltd, Singapore.

出版信息

Singapore Med J. 2022 Jun;63(6):313-318. doi: 10.11622/smedj.2020170. Epub 2020 Dec 2.

DOI:10.11622/smedj.2020170
PMID:36043308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9329555/
Abstract

INTRODUCTION

The Kidney Failure Risk Equation (KFRE) was developed to predict the risk of progression to end-stage kidney disease (ESKD). Although the KFRE has been validated in multinational cohorts, the Southeast Asian population was under-represented. This study aimed to validate the KFRE in a multi-ethnic Singapore chronic kidney disease (CKD) cohort.

METHODS

Stage 3-5 CKD patients referred to the renal medicine department at Singapore General Hospital in 2009 were included. The primary outcome (time to ESKD) was traced until 30 June 2017. The eight- and four-variable KFRE (non-North America) models using age, gender, estimated glomerular filtration rate, urine albumin-creatinine ratio, serum albumin, phosphate, bicarbonate and calcium were validated in our cohort. Cox regression, likelihood ratio (Χ), adequacy index, Harrell's C-index and calibration curves were calculated to assess the predictive performance, discrimination and calibration of these models on the cohort.

RESULTS

A total of 1,128 patients were included. During the study period, 252 (22.3%) patients reached ESKD at a median time to ESKD of 84.8 (range 0.1-104.7) months. Both the eight- and four-variable KFRE models showed excellent predictive performance and discrimination (eight-variable: C-index 0.872, 95% confidence interval [CI] 0.850-0.894, adequacy index 97.3%; four-variable: C-index 0.874, 95% CI 0.852-0.896, adequacy index 97.9%). There was no incremental improvement in the prediction ability of the eight-variable model over the four-variable model in this cohort.

CONCLUSION

The KFRE was validated in a multi-ethnic Singapore CKD cohort. This risk score may help to identify patients requiring early renal care.

摘要

简介

肾衰竭风险方程(KFRE)是为预测终末期肾病(ESKD)进展风险而开发的。尽管 KFRE 已经在多国队列中得到验证,但东南亚人群的代表性不足。本研究旨在验证 KFRE 在新加坡多民族慢性肾脏病(CKD)队列中的适用性。

方法

纳入 2009 年在新加坡总医院肾脏医学科就诊的 3-5 期 CKD 患者。主要结局(ESKD 时间)一直追踪到 2017 年 6 月 30 日。使用年龄、性别、估算肾小球滤过率、尿白蛋白-肌酐比、血清白蛋白、磷酸盐、碳酸氢盐和钙,对非北美地区的 KFRE 八变量和四变量模型在本队列中进行了验证。使用 Cox 回归、似然比(Χ)、充分性指数、Harrell's C 指数和校准曲线评估这些模型在队列中的预测性能、区分度和校准度。

结果

共纳入 1128 例患者。在研究期间,252 例(22.3%)患者达到 ESKD,中位 ESKD 时间为 84.8(范围 0.1-104.7)个月。八变量和四变量 KFRE 模型均显示出良好的预测性能和区分度(八变量:C 指数 0.872,95%置信区间 [CI] 0.850-0.894,充分性指数 97.3%;四变量:C 指数 0.874,95%CI 0.852-0.896,充分性指数 97.9%)。在本队列中,八变量模型在预测能力上没有比四变量模型有显著提高。

结论

KFRE 在新加坡多民族 CKD 队列中得到验证。该风险评分有助于识别需要早期肾脏护理的患者。